I know everything I am looking for is here, watch movies, watch series, education, games, exams, news, current events and many more.
As a university student, Dalton Signor was troubled by how many people around him smoked or vaped, including his grandmother and 14-year-old sister. Signor (pictured center) felt that existing smoking cessation medicines, whether patches, gums, or lozenges, are not very effective because they take too long to start working. “They take about 30 minutes to…
Google’s X “moonshot factory” this week announced its latest graduate. Heritable Agriculture is a data- and machine learning-driven startup aiming to improve how crops are grown. As the firm noted in an announcement post published Tuesday, plants are incredibly efficient and impressive systems. “Plants are solar powered, carbon negative, self-assembling machines that feed on sunlight…
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an AI-powered drug discovery startup, Manas AI. The company, which will initially focus on breast cancer, prostate cancer, and lymphoma, has raised $24.6 million in seed funding from Hoffman, General Catalyst, and Greylock. Manas…
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Altman previously provided Retro Biosciences’ entire seed round of $180 million. Now, the startup is raising a $1 billion Series A that…
Stockholm startup Neko Health has made a big bet on consumers wanting to learn about their state of health and how to prevent things going wrong. Now, investors are making a big bet on Neko. The startup has raised a fresh $260 million in funding, a Series B that values Neko at $1.8 billion post-money,…
A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development, in turn spurring demand for a streamlined clinical trial process to help get new…
You can’t start a company without a healthy dose of daring, and that’s certainly the case with NeuroBionics. The MIT-spinout thinks it could one day improve the lives of millions of people who live with neurological conditions like depression, epilepsy and Parkinson’s disease. Famed investor Steve Jurvetson of Future Ventures said that if everything goes…
Around the world, public healthcare systems have struggled to reset post-pandemic, and in particular, the increasingly aged populations in Western countries are putting pressure on services, not least in the UK where ‘NHS in crisis’ is a regular headline in the media. As a result, private companies, many powered with technology, see a gap in…
The white cane for the 21st century. While many tech companies have increasingly worked to make technology more accessible for the blind and visually impaired, canes haven’t benefited much from these advances. London-born WeWalk takes a more traditional approach to the white cane. Beyond the bulkier handle, not much sets the company’s product apart visually…
People with chronic kidney disease, or those at risk of heart failure, are greatly affected by potassium imbalances in the body. These can even be life-threatening. While wearable glucose monitors are now commonplace and have transformed the lives of diabetes patients, potassium monitoring is in its infancy as it’s hard to do. Now, startups are…